“We know there’s been no studies done on pregnancies and COVID vaccines and at the same time we know the emergency use authorizations allows for them to be given to pregnant women,” Berger said.
Although not about this particular concern, Johnson & Johnson released this statement regarding the vaccine:
“Johnson & Johnson continues to develop and test its COVID-19 vaccine candidate in accordance with ethical standards and sound scientific principles. The company is committed to transparency and sharing information related to its ongoing clinical studies.”
If authorized for emergency use, J&J said it can deliver 20 million doses by the end of March and a total of 100 million by the end of June.